Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-01-20 @ 11:15 PM
Study NCT ID:
NCT05211167
Status:
UNKNOWN
Last Update Posted:
2022-01-27
First Post:
2022-01-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure
Sponsor:
Shenyang Sunshine Pharmaceutical Co., LTD.
Organization: